Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Altimmune, Inc. | Director | Stock Options (option to buy) | 34.9K | Sep 26, 2024 | Direct | ||
Provention Bio, Inc. | Director | Common Stock | 0 | $24.32 | Apr 27, 2023 | Direct | |
Provention Bio, Inc. | Director | Option to Purchase Common Stock | 0 | Apr 27, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALT | Altimmune, Inc. | Sep 26, 2024 | 1 | $0 | 4 | Sep 30, 2024 | Director |
ALT | Altimmune, Inc. | Sep 28, 2023 | 1 | $0 | 4 | Sep 29, 2023 | Director |
PRVB | Provention Bio, Inc. | Apr 27, 2023 | 6 | $0 | 4 | Apr 27, 2023 | Director |
ALT | Altimmune, Inc. | Dec 22, 2022 | 3 | -$248K | 4 | Dec 22, 2022 | Director |
ALT | Altimmune, Inc. | Sep 29, 2022 | 1 | $0 | 4 | Sep 30, 2022 | Director |
PRVB | Provention Bio, Inc. | May 17, 2022 | 1 | $0 | 4 | May 18, 2022 | Director |
ALT | Altimmune, Inc. | Sep 23, 2021 | 1 | $0 | 4 | Sep 24, 2021 | Director |
PRVB | Provention Bio, Inc. | May 12, 2021 | 1 | $0 | 4 | May 14, 2021 | Director |